PRESS RELEASE published on 05/05/2023 at 12:00, 3 years 1 month ago EQS-Adhoc: Borussia Dortmund publishes preliminary figures for the third quarter (Q3) of the 2022/2023 financial year
PRESS RELEASE published on 04/20/2023 at 17:34, 3 years 2 months ago Positive decision in DFL licensing proceeding
PRESS RELEASE published on 03/15/2023 at 14:00, 3 years 3 months ago Matthias Bäumer new member of the Supervisory Board
PRESS RELEASE published on 02/17/2023 at 12:00, 3 years 4 months ago EQS-Adhoc: Borussia Dortmund GmbH & Co. KGaA: Borussia Dortmund reports preliminary figures for the first half (H1) of the 2022/2023 financial year
Published on 06/26/2026 at 13:00, 43 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 12 hours 3 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 14 hours 13 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 15 hours 13 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 13:32, 11 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 12 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 13 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 13:00, 43 minutes ago Schweizer Electronic and Ascent Circuits Plan Strategic Indo-German PCB Cooperation
Published on 06/26/2026 at 07:00, 6 hours 43 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 43 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 58 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 19 hours 13 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
